Results 101 to 110 of about 6,905 (171)

Computer-aided repositioning and functional <i>in vitro</i> assessment of novel PAD4 inhibitors. [PDF]

RSC Med Chem
Ruiz-Hernández S, Ochoa-González FL, Castañeda-Delgado JE, Galicia-Cruz OG, Castillo-Velázquez R, Comas-García M, Rivera G, Lara-Ramírez EE.   +7 more
europepmc   +1 more source

Estimating the changing prevalence of molecular markers of artemisinin partial resistance in Plasmodium falciparum malaria in Sub-Saharan Africa

Harrison LE, Golding N, Hao T, Botha I, van Wyk S, Mategula D, Dahal P, Raman J, Weiss DJ, Barnes KI, Guérin PJ, Flegg JA.   +11 more
europepmc   +1 more source

Plasmodium falciparum isolates: ex vivo drug response. [PDF]

J Antimicrob Chemother
Adika E, Saiid S, Amoako EK, Sakyi ME, Osumanu A, Morang'a C, Dosoo D, Chirawurah JD, Awandare GA, Amambua-Ngwa A, Aniweh Y, Amenga-Etego LN.   +11 more
europepmc   +1 more source

Genomic Surveillance of malaria reveals localized sporadic emergence of artemisinin partial resistance and wide-spread sulfadoxine-pyrimethamine resistance in Ghana

Dorvi IN, Kudakpo AY, Mensah C, Ngoi JM, Bandoh K, Ayeke DY, Mpere ME, Kuma CMK, Ahmed O, Sakyi M, Bamfo-Ennin R, Donkor E, Malm F, Ampeh EM, Mettle DNA, Yemi B, Tei-Maya F, Amoako EK, Unlu E, Dzabeng F, Morang’a CM, Amuzu DSY, Awandare GA, Amambua-Ngwa A, Amenga-Etego LN.   +24 more
europepmc   +1 more source

Trajectory of <i>Plasmodium falciparum</i> Molecular Markers of Amodiaquine Resistance in São Tomé and Príncipe. [PDF]

Open Forum Infect Dis
Té S, Das Neves E, Pellicer A, Broumou I, Zerebinski J, Santos-Reis A, Nóbrega de Sousa T, Färnert A, Santos A, Santos MJ, Gil JP, Lopes D.   +11 more
europepmc   +1 more source

CMCL-DDI: Pharmacophore-aware cross-view contrastive learning for drug-drug interaction prediction. [PDF]

PLoS One
Han Y, Du L.
europepmc   +1 more source

Malaria in children aged <6 months: a narrative review of current evidence, recommendations and practice gaps. [PDF]

Trop Med Health
Dalsuco J, Bassat Q, Ahmed H, Pfeffer S, Winnips C, Boulton C, Otsyula N, D'Alessandro U.   +7 more
europepmc   +1 more source

Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda: a promising approach for managing therapies in malaria-endemic countries. [PDF]

BMJ Glob Health
Muvunyi CM, Gashema P, Mbituyumuremyi A, Iradukunda PG, Siddig EE, Niyonzima JD, Hakizimana E, Umulisa N, Noor AM, Mugabo Semahore J, Tuyishime A, Harelimana JD, Umuhire J, Butera Y, Nsanzimana S.   +14 more
europepmc   +1 more source

Evaluation of in vitro drug-drug interactions of ivermectin and antimalarial compounds. [PDF]

Malar J
Tipthara P, Kullasakboonsri R, Kobylinski KC, Tarning J.   +3 more
europepmc   +1 more source

Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatment. [PDF]

Malar J
Laird VR, Plucinski MM, Venkatesan M, Rondini KA, Randrianarivelojosia M, Andriamananjara MN, Moonga H, Ishengoma DS, Chidimatembue A, Dimbu PR, Adeothy AL, Beavogui AH, Kariuki S, Nsobya SL, Uwimana A, Kahunu GM, Assefa A, Koita OA, Lucchi NW, Souza SSS, Zhou Z, Moriarty LF, Halsey ES.   +22 more
europepmc   +1 more source